Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01659918 · ClinicalTrials.gov registry record · Early Phase 1
Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
A Early Phase 1 study of Asthma, sponsored by Roxane Laboratories.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT01659918: Completed Early Phase 1 study of Asthma, sponsored by Roxane Laboratories.
NCT01659918 is a Early Phase 1 study of Asthma that has completed, run by Roxane Laboratories. The registered enrollment target is 35 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01659918, a Early Phase 1 study of Asthma, has completed, sponsored by Roxane Laboratories.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to prove the bioequivalence of Montelukast Tablet under fed conditions
Conditions Studied
Interventions
- DRUG Montelukast
- DRUG Singulair
Study Locations (1)
North Dakota
- PRACS Institute, Ltd. - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-02 |
| Phase | Early Phase 1 |
What the finished NCT01659918 record still lists
NCT01659918 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Montelukast is the first listed.
NCT01659918 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT01659918 about?
NCT01659918 is a clinical study titled "Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions". The objective of this study was to prove the bioequivalence of Montelukast Tablet under fed conditions
What is the current status of trial NCT01659918?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 35 participants. The study started on 2008-02. Estimated completion is 2008-02.
What conditions does trial NCT01659918 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01659918?
The interventions under investigation include: Montelukast (DRUG), Singulair (DRUG).
Who is sponsoring clinical trial NCT01659918?
This trial is sponsored by Roxane Laboratories, which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01659918 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01659918's enrollment target sits among peer trials
35 293rd of 374 higher than 81 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vaginal Microbiome Exposure and Immune Responses in C-section Infants
ACTIVE NOT RECRUITING · Early Phase 1
-
Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
COMPLETED · Early Phase 1
-
The Leaky Lung Test
COMPLETED · Early Phase 1
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia